Cargando…
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that target multiple aspects of the cancer-immunity cycl...
Autores principales: | Strauss, Bryan E, Silva, Gissele Rolemberg Oliveira, de Luna Vieira, Igor, Cerqueira, Otto Luiz Dutra, Del Valle, Paulo Roberto, Medrano, Ruan Felipe Vieira, Mendonça, Samir Andrade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113850/ https://www.ncbi.nlm.nih.gov/pubmed/30208166 http://dx.doi.org/10.6061/clinics/2018/e479s |
Ejemplares similares
-
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation
por: Cerqueira, Otto Luiz Dutra, et al.
Publicado: (2020) -
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022) -
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
por: Catani, João Paulo Portela, et al.
Publicado: (2016) -
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
por: Medrano, Ruan F.V., et al.
Publicado: (2017)